Chemotherapy-related amenorrhea (CRA) after adjuvant trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT trial) Meeting Abstract
| Authors: | Ruddy, K. J.; Trippa, L.; Hu, J.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Isakoff, S. J.; Valero, V. V.; Faggen, M. G.; Mulvey, T. M.; Bose, R.; Weckstein, D. J.; Wolff, A. C.; Reeder-Hayes, K. E.; Rugo, H. S.; Ramaswamy, B.; Zuckerman, D. S.; Hart, L. L.; Gadi, V. K.; Constantine, M.; Cheng, K. L.; Briccetti, F. M.; Schneider, B. P.; Garrett, A. M.; Marcom, P. K.; Albain, K. S.; DeFusco, P. A.; Tung, N. M.; Ardman, B. M.; Nanda, R.; Jankowitz, R. C.; DeMeo, M. K.; Burstein, H. J.; Winer, E. P.; Krop, I. E.; Partridge, A. H.; Tolaney, S. M. |
| Abstract Title: | Chemotherapy-related amenorrhea (CRA) after adjuvant trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT trial) |
| Meeting Title: | 42nd Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000527012501123 |
| DOI: | 10.1158/1538-7445.Sabcs19-p2-13-02 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-13-02 -- Source: Wos |
